Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 94 entries
Sorted by: Best Match Show Resources per page
A Systematic Review of Strategies for Implementing Empirically Supported Mental Health Interventions.

Research on social work practice

Powell BJ, Proctor EK, Glass JE.
PMID: 24791131
Res Soc Work Pract. 2014 Mar 01;24(2):192-212. doi: 10.1177/1049731513505778.

OBJECTIVE: This systematic review examines experimental studies that test the effectiveness of strategies intended to integrate empirically supported mental health interventions into routine care settings. Our goal was to characterize the state of the literature and to provide direction...

Cite
Powell BJ, Proctor EK, Glass JE. A Systematic Review of Strategies for Implementing Empirically Supported Mental Health Interventions. Res Soc Work Pract. 2014;24(2):192-212doi: 10.1177/1049731513505778.
Powell, B. J., Proctor, E. K., & Glass, J. E. (2014). A Systematic Review of Strategies for Implementing Empirically Supported Mental Health Interventions. Research on social work practice, 24(2), 192-212. https://doi.org/10.1177/1049731513505778
Powell, Byron J, et al. "A Systematic Review of Strategies for Implementing Empirically Supported Mental Health Interventions." Research on social work practice vol. 24,2 (2014): 192-212. doi: https://doi.org/10.1177/1049731513505778
Powell BJ, Proctor EK, Glass JE. A Systematic Review of Strategies for Implementing Empirically Supported Mental Health Interventions. Res Soc Work Pract. 2014 Mar 01;24(2):192-212. doi: 10.1177/1049731513505778. PMID: 24791131; PMCID: PMC4002057.
Copy Download .nbib Format: NLM
The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults.

Pharmacogenetics and genomics

Armamento-Villareal R, Wingkun N, Aguirre LE, Kulkarny V, Napoli N, Colleluori G, Qualls C, Villareal DT.
PMID: 26709911
Pharmacogenet Genomics. 2016 Apr;26(4):154-160. doi: 10.1097/FPC.0000000000000201.

OBJECTIVE: Fat mass and obesity-associated (FTO) gene polymorphisms have been reported to be associated with differences in BMI, obesity, and type 2 diabetes. However, previous studies have been predominantly conducted in younger individuals across a spectrum of body weights,...

Cite
Armamento-Villareal R, Wingkun N, Aguirre LE, et al. The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenet Genomics. 2016;26(4):154-160doi: 10.1097/FPC.0000000000000201.
Armamento-Villareal, R., Wingkun, N., Aguirre, L. E., Kulkarny, V., Napoli, N., Colleluori, G., Qualls, C., & Villareal, D. T. (2016). The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenetics and genomics, 26(4), 154-160. https://doi.org/10.1097/FPC.0000000000000201
Armamento-Villareal, Reina, et al. "The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults." Pharmacogenetics and genomics vol. 26,4 (2016): 154-160. doi: https://doi.org/10.1097/FPC.0000000000000201
Armamento-Villareal R, Wingkun N, Aguirre LE, Kulkarny V, Napoli N, Colleluori G, Qualls C, Villareal DT. The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adults. Pharmacogenet Genomics. 2016 Apr;26(4):154-160. doi: 10.1097/FPC.0000000000000201. PMID: 26709911; PMCID: PMC4919233.
Copy Download .nbib Format: NLM
Assessing the Straightforwardly-Worded Brief Fear of Negative Evaluation Scale for Differential Item Functioning Across Gender and Ethnicity.

Journal of psychopathology and behavioral assessment

Harpole JK, Levinson CA, Woods CM, Rodebaugh TL, Weeks JW, Brown PJ, Heimberg RG, Menatti AR, Blanco C, Schneier F, Liebowitz M.
PMID: 27642228
J Psychopathol Behav Assess. 2015 Jun;37(2):306-317. doi: 10.1007/s10862-014-9455-9. Epub 2014 Sep 05.

The Brief Fear of Negative Evaluation Scale (BFNE; Leary

Cite
Harpole JK, Levinson CA, Woods CM, et al. Assessing the Straightforwardly-Worded Brief Fear of Negative Evaluation Scale for Differential Item Functioning Across Gender and Ethnicity. J Psychopathol Behav Assess. 2014;37(2):306-317doi: 10.1007/s10862-014-9455-9.
Harpole, J. K., Levinson, C. A., Woods, C. M., Rodebaugh, T. L., Weeks, J. W., Brown, P. J., Heimberg, R. G., Menatti, A. R., Blanco, C., Schneier, F., & Liebowitz, M. (2015). Assessing the Straightforwardly-Worded Brief Fear of Negative Evaluation Scale for Differential Item Functioning Across Gender and Ethnicity. Journal of psychopathology and behavioral assessment, 37(2), 306-317. https://doi.org/10.1007/s10862-014-9455-9
Harpole, Jared K, et al. "Assessing the Straightforwardly-Worded Brief Fear of Negative Evaluation Scale for Differential Item Functioning Across Gender and Ethnicity." Journal of psychopathology and behavioral assessment vol. 37,2 (2015): 306-317. doi: https://doi.org/10.1007/s10862-014-9455-9
Harpole JK, Levinson CA, Woods CM, Rodebaugh TL, Weeks JW, Brown PJ, Heimberg RG, Menatti AR, Blanco C, Schneier F, Liebowitz M. Assessing the Straightforwardly-Worded Brief Fear of Negative Evaluation Scale for Differential Item Functioning Across Gender and Ethnicity. J Psychopathol Behav Assess. 2015 Jun;37(2):306-317. doi: 10.1007/s10862-014-9455-9. Epub 2014 Sep 05. PMID: 27642228; PMCID: PMC5026324.
Copy Download .nbib Format: NLM
Behavioral Weight Loss Treatment in Antipsychotic Treated Youth.

Scandinavian journal of child and adolescent psychiatry and psychology

Nicol GE, Kolko RP, Mills M, Gunnarsdottir T, Yingling MD, Schweiger JA, Lenze EJ, Newcomer JW, Wilfley D.
PMID: 27347489
Scand J Child Adolesc Psychiatr Psychol. 2016 May;4(2):96-104. doi: 10.21307/sjcapp-2016-014.

BACKGROUND: Antipsychotic-treated youth have increased risk for the development of obesity and type 2 diabetes. Behavioral weight loss treatments show promise in reducing obesity and diabetes risk in antipsychotic treated adults, but have received no study in antipsychotic treated...

Cite
Nicol GE, Kolko RP, Mills M, et al. Behavioral Weight Loss Treatment in Antipsychotic Treated Youth. Scand J Child Adolesc Psychiatr Psychol. 2016;4(2):96-104doi: 10.21307/sjcapp-2016-014.
Nicol, G. E., Kolko, R. P., Mills, M., Gunnarsdottir, T., Yingling, M. D., Schweiger, J. A., Lenze, E. J., Newcomer, J. W., & Wilfley, D. (2016). Behavioral Weight Loss Treatment in Antipsychotic Treated Youth. Scandinavian journal of child and adolescent psychiatry and psychology, 4(2), 96-104. https://doi.org/10.21307/sjcapp-2016-014
Nicol, Ginger E, et al. "Behavioral Weight Loss Treatment in Antipsychotic Treated Youth." Scandinavian journal of child and adolescent psychiatry and psychology vol. 4,2 (2016): 96-104. doi: https://doi.org/10.21307/sjcapp-2016-014
Nicol GE, Kolko RP, Mills M, Gunnarsdottir T, Yingling MD, Schweiger JA, Lenze EJ, Newcomer JW, Wilfley D. Behavioral Weight Loss Treatment in Antipsychotic Treated Youth. Scand J Child Adolesc Psychiatr Psychol. 2016 May;4(2):96-104. doi: 10.21307/sjcapp-2016-014. PMID: 27347489; PMCID: PMC4916921.
Copy Download .nbib Format: NLM
Windlass Mechanism in Individuals With Diabetes Mellitus, Peripheral Neuropathy, and Low Medial Longitudinal Arch Height.

Foot & ankle international

Gelber JR, Sinacore DR, Strube MJ, Mueller MJ, Johnson JE, Prior FW, Hastings MK.
PMID: 24917647
Foot Ankle Int. 2014 Aug;35(8):816-824. doi: 10.1177/1071100714538416. Epub 2014 Jun 10.

BACKGROUND: The windlass mechanism, acting through the plantar fascia, stabilizes the arches of the foot during stance phase of gait. The purpose of this study was to compare changes in radiographic measurements of the medial longitudinal arch (MLA) between...

Cite
Gelber JR, Sinacore DR, Strube MJ, et al. Windlass Mechanism in Individuals With Diabetes Mellitus, Peripheral Neuropathy, and Low Medial Longitudinal Arch Height. Foot Ankle Int. 2014;35(8):816-824doi: 10.1177/1071100714538416.
Gelber, J. R., Sinacore, D. R., Strube, M. J., Mueller, M. J., Johnson, J. E., Prior, F. W., & Hastings, M. K. (2014). Windlass Mechanism in Individuals With Diabetes Mellitus, Peripheral Neuropathy, and Low Medial Longitudinal Arch Height. Foot & ankle international, 35(8), 816-824. https://doi.org/10.1177/1071100714538416
Gelber, Judith R, et al. "Windlass Mechanism in Individuals With Diabetes Mellitus, Peripheral Neuropathy, and Low Medial Longitudinal Arch Height." Foot & ankle international vol. 35,8 (2014): 816-824. doi: https://doi.org/10.1177/1071100714538416
Gelber JR, Sinacore DR, Strube MJ, Mueller MJ, Johnson JE, Prior FW, Hastings MK. Windlass Mechanism in Individuals With Diabetes Mellitus, Peripheral Neuropathy, and Low Medial Longitudinal Arch Height. Foot Ankle Int. 2014 Aug;35(8):816-824. doi: 10.1177/1071100714538416. Epub 2014 Jun 10. PMID: 24917647; PMCID: PMC4262736.
Copy Download .nbib Format: NLM
The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.

Journal of geriatric oncology

Wildes TM, Kallogjeri D, Powers B, Vlahiotis A, Mutch M, Spitznagel EL, Tan B, Piccirillo JF.
PMID: 21113435
J Geriatr Oncol. 2010 Oct 01;1(2):48-56. doi: 10.1016/j.jgo.2010.08.003.

OBJECTIVES: To determine the combined effect of age and comorbidity on receipt of chemotherapy and its impact on survival in elderly patients with stage III colorectal cancer (CRC). MATERIALS AND METHODS: All patients over age 65 with Stage III...

Cite
Wildes TM, Kallogjeri D, Powers B, et al. The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity. J Geriatr Oncol. 2010;1(2):48-56doi: 10.1016/j.jgo.2010.08.003.
Wildes, T. M., Kallogjeri, D., Powers, B., Vlahiotis, A., Mutch, M., Spitznagel, E. L., Tan, B., & Piccirillo, J. F. (2010). The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity. Journal of geriatric oncology, 1(2), 48-56. https://doi.org/10.1016/j.jgo.2010.08.003
Wildes, Tanya M, et al. "The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity." Journal of geriatric oncology vol. 1,2 (2010): 48-56. doi: https://doi.org/10.1016/j.jgo.2010.08.003
Wildes TM, Kallogjeri D, Powers B, Vlahiotis A, Mutch M, Spitznagel EL, Tan B, Piccirillo JF. The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity. J Geriatr Oncol. 2010 Oct 01;1(2):48-56. doi: 10.1016/j.jgo.2010.08.003. PMID: 21113435; PMCID: PMC2989633.
Copy Download .nbib Format: NLM
A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome.

Journal of neurodevelopmental disorders

Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, Senturk D, Schneider A, Lightbody A, Reiss AL, Hall S.
PMID: 19865612
J Neurodev Disord. 2009 Mar;1(1):33-45. doi: 10.1007/s11689-008-9001-8.

Intelligence testing in children with intellectual disabilities (ID) has significant limitations. The normative samples of widely used intelligence tests, such as the Wechsler Intelligence Scales, rarely include an adequate number of subjects with ID needed to provide sensitive measurement...

Cite
Hessl D, Nguyen DV, Green C, et al. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. J Neurodev Disord. 2009;1(1):33-45doi: 10.1007/s11689-008-9001-8.
Hessl, D., Nguyen, D. V., Green, C., Chavez, A., Tassone, F., Hagerman, R. J., Senturk, D., Schneider, A., Lightbody, A., Reiss, A. L., & Hall, S. (2009). A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. Journal of neurodevelopmental disorders, 1(1), 33-45. https://doi.org/10.1007/s11689-008-9001-8
Hessl, David, et al. "A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome." Journal of neurodevelopmental disorders vol. 1,1 (2009): 33-45. doi: https://doi.org/10.1007/s11689-008-9001-8
Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, Senturk D, Schneider A, Lightbody A, Reiss AL, Hall S. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. J Neurodev Disord. 2009 Mar;1(1):33-45. doi: 10.1007/s11689-008-9001-8. PMID: 19865612; PMCID: PMC2768415.
Copy Download .nbib Format: NLM
Intermuscular adipose tissue is muscle specific and associated with poor functional performance.

Journal of aging research

Tuttle LJ, Sinacore DR, Mueller MJ.
PMID: 22666591
J Aging Res. 2012;2012:172957. doi: 10.1155/2012/172957. Epub 2012 May 14.

Purpose. People with obesity, diabetes, and peripheral neuropathy have high levels of intermuscular adipose tissue (IMAT) volume which has been inversely related to physical function. We determined if IMAT is muscle specific, if calf IMAT is different between a...

Cite
Tuttle LJ, Sinacore DR, Mueller MJ. Intermuscular adipose tissue is muscle specific and associated with poor functional performance. J Aging Res. 2012;2012:172957doi: 10.1155/2012/172957.
Tuttle, L. J., Sinacore, D. R., & Mueller, M. J. (2012). Intermuscular adipose tissue is muscle specific and associated with poor functional performance. Journal of aging research, 2012172957. https://doi.org/10.1155/2012/172957
Tuttle, Lori J, et al. "Intermuscular adipose tissue is muscle specific and associated with poor functional performance." Journal of aging research vol. 2012 (2012): 172957. doi: https://doi.org/10.1155/2012/172957
Tuttle LJ, Sinacore DR, Mueller MJ. Intermuscular adipose tissue is muscle specific and associated with poor functional performance. J Aging Res. 2012;2012:172957. doi: 10.1155/2012/172957. Epub 2012 May 14. PMID: 22666591; PMCID: PMC3361226.
Copy Download .nbib Format: NLM
Neuropathic midfoot deformity: associations with ankle and subtalar joint motion.

Journal of foot and ankle research

Sinacore DR, Gutekunst DJ, Hastings MK, Strube MJ, Bohnert KL, Prior FW, Johnson JE.
PMID: 23531372
J Foot Ankle Res. 2013 Mar 25;6(1):11. doi: 10.1186/1757-1146-6-11.

BACKGROUND: Neuropathic deformities impair foot and ankle joint mobility, often leading to abnormal stresses and impact forces. The purpose of our study was to determine differences in radiographic measures of hind foot alignment and ankle joint and subtalar joint...

Cite
Sinacore DR, Gutekunst DJ, Hastings MK, et al. Neuropathic midfoot deformity: associations with ankle and subtalar joint motion. J Foot Ankle Res. 2013;6(1):11doi: 10.1186/1757-1146-6-11.
Sinacore, D. R., Gutekunst, D. J., Hastings, M. K., Strube, M. J., Bohnert, K. L., Prior, F. W., & Johnson, J. E. (2013). Neuropathic midfoot deformity: associations with ankle and subtalar joint motion. Journal of foot and ankle research, 6(1), 11. https://doi.org/10.1186/1757-1146-6-11
Sinacore, David R, et al. "Neuropathic midfoot deformity: associations with ankle and subtalar joint motion." Journal of foot and ankle research vol. 6,1 (2013): 11. doi: https://doi.org/10.1186/1757-1146-6-11
Sinacore DR, Gutekunst DJ, Hastings MK, Strube MJ, Bohnert KL, Prior FW, Johnson JE. Neuropathic midfoot deformity: associations with ankle and subtalar joint motion. J Foot Ankle Res. 2013 Mar 25;6(1):11. doi: 10.1186/1757-1146-6-11. PMID: 23531372; PMCID: PMC3616933.
Copy Download .nbib Format: NLM
Why and when should we use public deliberation?.

The Hastings Center report

Solomon S, Abelson J.
PMID: 22733325
Hastings Cent Rep. 2012 Mar-Apr;42(2):17-20. doi: 10.1002/hast.27.

No abstract available.

Cite
Solomon S, Abelson J. Why and when should we use public deliberation?. Hastings Cent Rep. 2012;42(2):17-20doi: 10.1002/hast.27.
Solomon, S., & Abelson, J. (2012). Why and when should we use public deliberation?. The Hastings Center report, 42(2), 17-20. https://doi.org/10.1002/hast.27
Solomon, Stephanie, and Abelson, Julia. "Why and when should we use public deliberation?." The Hastings Center report vol. 42,2 (2012): 17-20. doi: https://doi.org/10.1002/hast.27
Solomon S, Abelson J. Why and when should we use public deliberation?. Hastings Cent Rep. 2012 Mar-Apr;42(2):17-20. doi: 10.1002/hast.27. PMID: 22733325; PMCID: PMC3645483.
Copy Download .nbib Format: NLM
A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome.

Statistical methods & applications

Gao F, Miller JP, Xiong C, Beiser JA, Gordon M.
PMID: 21339862
Stat Methods Appt. 2011 Mar 01;20(1):83-100. doi: 10.1007/s10260-010-0150-z.

In some clinical trials and epidemiologic studies, investigators are interested in knowing whether the variability of a biomarker is independently predictive of clinical outcomes. This question is often addressed via a naïve approach where a sample-based estimate (e.g., standard...

Cite
Gao F, Miller JP, Xiong C, et al. A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome. Stat Methods Appt. 2011;20(1):83-100doi: 10.1007/s10260-010-0150-z.
Gao, F., Miller, J. P., Xiong, C., Beiser, J. A., Gordon, M. (2011). A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome. Statistical methods & applications, 20(1), 83-100. https://doi.org/10.1007/s10260-010-0150-z
Gao, Feng, et al. "A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome." Statistical methods & applications vol. 20,1 (2011): 83-100. doi: https://doi.org/10.1007/s10260-010-0150-z
Gao F, Miller JP, Xiong C, Beiser JA, Gordon M. A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome. Stat Methods Appt. 2011 Mar 01;20(1):83-100. doi: 10.1007/s10260-010-0150-z. PMID: 21339862; PMCID: PMC3039885.
Copy Download .nbib Format: NLM
Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy.

Cardiorenal medicine

Fraterrigo G, Fabbrini E, Mittendorfer B, O'Rahilly S, Scherer PE, Patterson BW, Klein S.
PMID: 22969777
Cardiorenal Med. 2012 Aug;2(3):211-217. doi: 10.1159/000340037. Epub 2012 Jul 18.

BACKGROUND: Niaspan® (extended-release niacin) is a nicotinic acid formulation used to treat dyslipidemia in obese subjects. Niaspan binds to the GPR109A receptor in adipose tissue and stimulates adiponectin secretion, which should improve insulin sensitivity. However, Niaspan therapy often causes...

Cite
Fraterrigo G, Fabbrini E, Mittendorfer B, et al. Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy. Cardiorenal Med. 2012;2(3):211-217doi: 10.1159/000340037.
Fraterrigo, G., Fabbrini, E., Mittendorfer, B., O'Rahilly, S., Scherer, P. E., Patterson, B. W., & Klein, S. (2012). Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy. Cardiorenal medicine, 2(3), 211-217. https://doi.org/10.1159/000340037
Fraterrigo, Gemma, et al. "Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy." Cardiorenal medicine vol. 2,3 (2012): 211-217. doi: https://doi.org/10.1159/000340037
Fraterrigo G, Fabbrini E, Mittendorfer B, O'Rahilly S, Scherer PE, Patterson BW, Klein S. Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy. Cardiorenal Med. 2012 Aug;2(3):211-217. doi: 10.1159/000340037. Epub 2012 Jul 18. PMID: 22969777; PMCID: PMC3433009.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 94 entries